GenBody

GenBody, Inc. was founded in 2012 and is committed to human and global health. GenBody develops technologies and raw materials for diagnostic solutions and provides integrated diagnostic solutions such as Rapid Diagnostic Tests (RDT), Fluorescent Immunoassay Diagnostic Tests (F-RDT), Enzyme-Linked Immunosorbent Assay (ELISA), Molecular Diagnostic Tests (MDx), and Biochemical Reagents (Biochemistry Reagent). With over 20 years of experience in the diagnostics industry and a vast bio-network established through collaborations with several key research institutes, universities, and hospitals, our core strength lies in R&D. We specialize in the development of monoclonal antibodies and recombinant antigens within our facilities in Korea. We also possess patented technologies, including fluorescent immunoassays, which will be one of the major IVD technologies of the future.